For Many Kids on ADHD Pills, It’s the Start of a Drug Cascade
Episode
23 min
Read time
2 min
AI-Generated Summary
Key Takeaways
- ✓Polypharmacy correlation data: Analysis of 166,000 Medicaid children from 2019-2023 shows kids on ADHD medication are more than five times as likely to be on additional psychiatric drugs four years later compared to non-medicated peers. This correlation is most pronounced when children start ADHD medications very young, with differences persisting across sex, race, and foster care status variations.
- ✓Side effect treatment spiral: ADHD stimulants commonly cause mood crashes and agitation as they wear off. Doctors often prescribe additional medications like Prozac to treat these side effects rather than recognizing them as drug-induced reactions. Each new medication creates its own side effects, leading to further prescriptions in what becomes an escalating cycle of polypharmacy throughout childhood development.
- ✓Research gap on drug combinations: Very little scientific research exists on how cocktails of multiple psychiatric medications affect developing brains in children. Psychiatrists openly acknowledge using trial and error approaches, adjusting doses and combinations based on fifteen-minute appointments rather than evidence-based protocols. One psychiatrist describes preschoolers on multiple medications as loose canons in their reactions.
- ✓Behavioral therapy access barriers: For children six and under, parent-child interaction therapy is recommended before medication, but parents report difficulty finding providers and taking time off work for appointments. This therapy requires six to nine months of intensive work. Stanford University study shows 42 percent of children aged three to five receive medication within thirty days of ADHD diagnosis, bypassing behavioral interventions.
- ✓Withdrawal severity and duration: Coming off layered psychiatric medications can take months or years, with each drug affecting the nervous system differently. Danielle reduces her antidepressant by one-tenth of a milligram at a time through a compound pharmacy because larger reductions cause unbearable symptoms including pain, shaking, vision loss, and cognitive dysfunction. She may never fully discontinue medications her brain developed on.
What It Covers
Wall Street Journal investigation reveals children prescribed ADHD medication at young ages are five times more likely to take additional psychiatric drugs four years later. Danielle Ganske's story illustrates this cascade: starting stimulants at age seven led to a two-page list of medications including antidepressants and anti-anxiety drugs, with severe withdrawal symptoms lasting years.
Key Questions Answered
- •Polypharmacy correlation data: Analysis of 166,000 Medicaid children from 2019-2023 shows kids on ADHD medication are more than five times as likely to be on additional psychiatric drugs four years later compared to non-medicated peers. This correlation is most pronounced when children start ADHD medications very young, with differences persisting across sex, race, and foster care status variations.
- •Side effect treatment spiral: ADHD stimulants commonly cause mood crashes and agitation as they wear off. Doctors often prescribe additional medications like Prozac to treat these side effects rather than recognizing them as drug-induced reactions. Each new medication creates its own side effects, leading to further prescriptions in what becomes an escalating cycle of polypharmacy throughout childhood development.
- •Research gap on drug combinations: Very little scientific research exists on how cocktails of multiple psychiatric medications affect developing brains in children. Psychiatrists openly acknowledge using trial and error approaches, adjusting doses and combinations based on fifteen-minute appointments rather than evidence-based protocols. One psychiatrist describes preschoolers on multiple medications as loose canons in their reactions.
- •Behavioral therapy access barriers: For children six and under, parent-child interaction therapy is recommended before medication, but parents report difficulty finding providers and taking time off work for appointments. This therapy requires six to nine months of intensive work. Stanford University study shows 42 percent of children aged three to five receive medication within thirty days of ADHD diagnosis, bypassing behavioral interventions.
- •Withdrawal severity and duration: Coming off layered psychiatric medications can take months or years, with each drug affecting the nervous system differently. Danielle reduces her antidepressant by one-tenth of a milligram at a time through a compound pharmacy because larger reductions cause unbearable symptoms including pain, shaking, vision loss, and cognitive dysfunction. She may never fully discontinue medications her brain developed on.
Notable Moment
After years on multiple medications, Danielle took the antipsychotic Zyprexa for withdrawal symptoms her doctor attributed to an underlying mood disorder. The first dose caused what she describes as a chemical lobotomy where she could not think or speak and felt trapped inside her body, experiencing a complete loss of cognitive function that terrified her.
You just read a 3-minute summary of a 20-minute episode.
Get The Journal summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from The Journal
Move Over, Humans. China's Robots Are Taking Over
Apr 29 · 20 min
The TWIML AI Podcast
How to Engineer AI Inference Systems with Philip Kiely - #766
Apr 30
More from The Journal
Inside Meta’s Big AI Pivot
Apr 28 · 21 min
Eye on AI
#341 Celia Merzbacher: Beyond the Buzzword: The Real State of Quantum Computing, Sensing, and AI in 2025
Apr 30
More from The Journal
We summarize every new episode. Want them in your inbox?
Similar Episodes
Related episodes from other podcasts
The TWIML AI Podcast
Apr 30
How to Engineer AI Inference Systems with Philip Kiely - #766
Eye on AI
Apr 30
#341 Celia Merzbacher: Beyond the Buzzword: The Real State of Quantum Computing, Sensing, and AI in 2025
Moonshots with Peter Diamandis
Apr 30
Google Invests $40B Into Anthropic, GPT 5.5 Drops, and Google Cloud Dominates | EP #252
Citeline Podcasts
Apr 30
Carna Health On Closing the Gap in CKD Prevention
Alt Goes Mainstream
Apr 30
Lincoln International's Brian Garfield - how is AI impacting private markets valuations?
This podcast is featured in Best News Podcasts (2026) — ranked and reviewed with AI summaries.
You're clearly into The Journal.
Every Monday, we deliver AI summaries of the latest episodes from The Journal and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime